Analysis – Page 19 – Goldea Capital

Catheter Precision Enters Distribution Agreement with FuMedica AG to Bring LockeT to Switzerland

Written by Customer Service on October 16, 2025. Posted in Public Companies.

FORT MILL, S.C., Oct. 16, 2025 (GLOBE NEWSWIRE) — Catheter Precision, Inc. (VTAK – NYSE/American), a US based medical device company and a leading developer of innovative solutions for cardiac procedures, is pleased to announce a strategic distribution agreement with FuMedica AG, a premier Swiss medical device distributor. This partnership will introduce Catheter Precision’s LockeT suture retention device to hospitals and clinics across Switzerland. LockeT is a novel suture retention tool designed to simplify and secure the closure of vascular access sites following cardiac procedures. Its intuitive design and reliable performance have made it a valuable addition to electrophysiology labs and interventional suites worldwide. FuMedica AG, based in Muri, Switzerland, has a long-standing reputation for excellence in distributing...

Cerence xUI Selected as AutoTech AI Solution of the Year by AutoTech Breakthrough

Written by Customer Service on October 16, 2025. Posted in Public Companies.

Annual awards program recognizes innovation in automotive and transportation technologies around the globe BURLINGTON, Mass., Oct. 16, 2025 (GLOBE NEWSWIRE) — Cerence Inc. (NASDAQ: CRNC) (“Cerence AI”), a global leader pioneering conversational AI-powered user experiences, today announced that its hybrid, agentic AI platform, Cerence xUI™, was named AutoTech AI Solution of the Year in the sixth annual AutoTech Breakthrough Awards program recognizing the top companies, technologies, and products in the global automotive and transportation technology markets. xUI – which has already been adopted by several leading automakers as the basis for their next-gen in-car assistants – is powered by CaLLM™, the company’s family of large and small language models. It offers multi-modal capabilities and seamlessly integrates third-party...

Doman Building Materials Group Ltd. to Issue Third Quarter 2025 Financial Results November 6, 2025

Written by Customer Service on October 16, 2025. Posted in Public Companies.

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. VANCOUVER, British Columbia, Oct. 16, 2025 (GLOBE NEWSWIRE) — Doman Building Materials Group Ltd. (“Doman” or “the Company”) (TSX: DBM) is pleased to announce that it will report its third quarter 2025 financial results for the period ended September 30, 2025, after market hours on Thursday, November 6, 2025. The Company will host an analyst call on Friday, November 7, 2025, at 11:00 a.m. ET. Amar Doman, Chairman of the Board and Chief Executive Officer, and James Code, Chief Financial Officer, will discuss the Company’s financial performance for the period ended September 30, 2025. To access the call, please dial 1-877-407-3982 or 1-201-493-6780. To join the...

Nuvini Provides FY2025 EBITDA Guidance and Business Outlook

Written by Customer Service on October 16, 2025. Posted in Public Companies.

NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) — Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading acquirer and operator of vertical market SaaS businesses in Latin America, today provided its fiscal year 2025 and outlined key drivers of its growth strategy. For the twelve months ending December 31, 2025, Nuvini expects to generate approximately R$50 to R$60 million of EBITDA, excluding the impact of acquisitions. At its current market value of roughly $45 million, the midpoint of guidance implies an EV/EBITDA multiple below 4.5x, underscoring the substantial disconnect between fundamentals and valuation. Targets in the Company’s current acquisitions pipeline with signed letters of intent, if acquired, would contribute to an increase in the Company’s annualized run-rate EBITDA to approximately R$85–95 million...

Karbon-X Corp. Reports Q1 2026 Revenue Growth and Strengthened Financial Position

Written by Customer Service on October 16, 2025. Posted in Earnings Releases And Operating Results.

Revenue reached $35.7 million, marking a 27,883% year-over-year increase driven by accelerated trading activity, and the continued expansion of Karbon-X’s global carbon operations. CALGARY, Alberta, Oct. 16, 2025 (GLOBE NEWSWIRE) — Karbon-X Corp. (OTCQX:KARX) (“Karbon-X” or “the Company”), a vertically integrated climate solutions company, today announced financial results for the first quarter ended August 31, 2025, marking record revenue growth and continued execution of its strategic plan. The full filing is available under the Company’s profile on OTC Markets at www.otcmarkets.com/stock/KARX/overview Karbon-X’s Q1 2026 results underscore its accelerating growth trajectory and strong execution across all areas of its business. Q1 2026 Highlights Karbon-X delivered transformational top-line growth as its carbon trading operations...

Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.

Written by Customer Service on October 16, 2025. Posted in Public Companies.

– Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation’s Most Trusted Health Care Distributors– Relationship Marks a Key Milestone in Biomerica’s Commercialization Strategy IRVINE, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) — Biomerica, Inc. (Nasdaq: BMRA), a global biomedical company, announced today a marketing services arrangement with Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, to market Biomerica’s inFoods® Irritable Bowel Syndrome (IBS) test in the United States, excluding New York State. Henry Schein’s powerful nationwide distribution network, comprised of more than 400 medical field sales and telesales representatives, will provide marketing support for the inFoods® IBS test to primary care...

Myseum Receives Notice of Patent Allowance for Advanced Digital Privacy Streaming Technology for Secure Video & Audio Communications

Written by Customer Service on October 16, 2025. Posted in Public Companies.

NEW BRUNSWICK, N.J., Oct. 16, 2025 (GLOBE NEWSWIRE) — Myseum, Inc. (Nasdaq: MYSE) (“Myseum” or the “Company”), a privacy-first social media and technology innovator, today announced that it has received a notice of allowance from the U.S Patent and Trademark Office (USPTO) for application #18/487,726 titled “Secure Web RTC Real Time Communications Service for Audio and Video Streaming Communications.” This new international patent further strengthens Myseum’s growing intellectual property portfolio and global leadership in next-generation digital privacy technology. “This new patent represents another important milestone in our domestic and global IP expansion,” said Darin Myman, Chief Executive Officer of Myseum. “So far this year, we have secured protection in four international markets, reinforcing the strength and versatility...

Kering: Monthly statement on the total number of shares and voting rights (October 2025)

Written by Customer Service on October 16, 2025. Posted in Public Companies.

Kering – Statement Number of Shares and voting rights – 15.10.2025 KeringSociété anonyme with a share capital of €493,683,112Head office: 40, rue de Sèvres – 75007 PARIS552 075 020 RCS PARIS October 16, 2025 Monthly statement on the total number of shares and voting rights(articles L.233-8 of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (AMF – Autorité des Marchés Financiers)Date Total number ofshares Total number of voting rightstheoretical 1 exercisable 2October 15, 2025 123,420,778 176,697,825 175,897,3581 Calculated based on all shares with voting rights, including treasury shares stripped of voting rights (Art. 223‑11 of AMF General Regulation). 2 Excluding treasury shares stripped of voting rights.Attachment...

Theriva™ Biologics Announces a Warrant Inducement Transaction for $4.0 Million in Gross Proceeds

Written by Customer Service on October 16, 2025. Posted in Public Companies.

ROCKVILLE, Md., Oct. 16, 2025 (GLOBE NEWSWIRE) — Theriva™ Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced its entry into a warrant inducement agreement with existing institutional investors of the Company for the immediate exercise of warrants to purchase up to 7,360,460 of common stock (the “Existing Warrants”) at a reduced exercise price of $0.54 per share for gross cash proceeds of approximately $4.0 million before deducting fees and other transaction expenses. The offer to exercise will remain open until 11:30 AM ET for up to an additional $0.4 million in gross proceeds. The Company intends to use the net proceeds from the warrant inducement transaction...

StepStone Real Estate Announces Program Size Increase of StepStone Real Estate Partners V to $5.3 Billion

Written by Customer Service on October 16, 2025. Posted in Public Companies.

NEW YORK, Oct. 16, 2025 (GLOBE NEWSWIRE) — StepStone Real Estate (“SRE”), the real estate arm of StepStone Group (NASDAQ: STEP), a global private markets investment firm, today announced that it has finalized the size of its StepStone Real Estate Partners V (“SREP V”) GP-led secondaries program, with total commitments of $5.3 billion. In April 2025, SRE announced it had closed $4.5 billion in total commitments for the program, which included a commingled fund of $3.77 billion and discretionary co-investment vehicles investing alongside the fund. As of September 30, 2025, SRE has secured an additional $800 million in discretionary co-investment commitments. To date, SREP V has committed to 12 investments totaling $3.2 billion including co-investments, with several compelling opportunities currently in its pipeline. The average SREP...

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals